TCM
GILD icon

Triumph Capital Management’s Gilead Sciences GILD Stock Holding History

Triumph Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
3,687
+80
+2% +$10.5K 0.08% 230
2026
Q1 		$503K Buy
3,607
+255
+8% +$35.7K 0.1% 187
2025
Q4 		$411K Buy
3,352
+38
+1% +$4.62K 0.09% 196
2025
Q3 		$368K Buy
3,314
+470
+17% +$53.4K 0.1% 216
2025
Q2 		$315K Sell
2,844
-46
-2% -$4.9K 0.09% 217
2025
Q1 		$324K Sell
2,890
-180
-6% -$18.6K 0.11% 205
2024
Q4 		$284K Sell
3,070
-84
-3% -$7.56K 0.1% 221
2024
Q3 		$264K Sell
3,154
-17,045
-84% -$1.3M 0.09% 224
2024
Q2 		$1.39M Buy
20,199
+12,271
+155% +$819K 0.54% 39
2024
Q1 		$578K Buy
+7,928
New +$610K 0.24% 104
2023
Q2 		– Sell
-2,455
Closed -$204K – 234
2023
Q1 		$204K Sell
2,455
-3
-0.1% -$248 0.1% 176
2022
Q4 		$211K Sell
2,458
-6,745
-73% -$534K 0.11% 183
2022
Q3 		$568K Buy
9,203
+546
+6% +$34.4K 0.31% 75
2022
Q2 		$535K Buy
8,657
+48
+0.6% +$2.97K 0.28% 85
2022
Q1 		$512K Buy
+8,609
New +$550K 0.22% 112

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Triumph Capital Management's GILD Position: Q2 2026 in Review

Triumph Capital Management increased its Gilead Sciences (GILD) stake by 2.2% in Q2 2026, buying an estimated $10.5K and bringing the position to 3,687 shares worth $466K. The position accounts for 0.08% of the portfolio, ranked #230.

Triumph Capital Management first reported a position in GILD in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.39M in Q2 2024. 508 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Triumph Capital Management held 3,687 shares of Gilead Sciences worth $466K as of Q2 2026.
  • Triumph Capital Management bought 80 Gilead Sciences shares in Q2 2026, an estimated $10.5K.
  • Gilead Sciences made up 0.08% of Triumph Capital Management's portfolio in Q2 2026, its #230 holding.
  • Triumph Capital Management first reported a position in Gilead Sciences in Q1 2022 and has held it in 15 quarters since.
  • Triumph Capital Management's Gilead Sciences position peaked at $1.39M in Q2 2024.
  • 508 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.